CECCATELLI BERTI, Camilla
 Distribuzione geografica
Continente #
NA - Nord America 2.452
AS - Asia 1.915
EU - Europa 1.281
SA - Sud America 273
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 95
OC - Oceania 14
Totale 6.156
Nazione #
US - Stati Uniti d'America 2.368
SG - Singapore 656
IT - Italia 547
CN - Cina 380
VN - Vietnam 354
BR - Brasile 173
HK - Hong Kong 145
IE - Irlanda 126
DE - Germania 115
SE - Svezia 112
BD - Bangladesh 97
FR - Francia 72
ZA - Sudafrica 61
CA - Canada 56
CL - Cile 56
GB - Regno Unito 52
NL - Olanda 51
IN - India 50
FI - Finlandia 45
RU - Federazione Russa 36
KR - Corea 35
JP - Giappone 33
BE - Belgio 24
AR - Argentina 19
ES - Italia 19
AT - Austria 18
PK - Pakistan 18
TR - Turchia 18
IQ - Iraq 17
MX - Messico 15
AU - Australia 13
ID - Indonesia 12
PH - Filippine 11
SA - Arabia Saudita 11
LT - Lituania 10
TH - Thailandia 9
TW - Taiwan 9
PL - Polonia 8
UZ - Uzbekistan 8
CH - Svizzera 7
CI - Costa d'Avorio 7
EC - Ecuador 7
KE - Kenya 7
MY - Malesia 7
MA - Marocco 6
UY - Uruguay 6
CO - Colombia 5
DK - Danimarca 5
ET - Etiopia 5
JO - Giordania 5
AZ - Azerbaigian 4
NP - Nepal 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GE - Georgia 3
GR - Grecia 3
IL - Israele 3
IR - Iran 3
LB - Libano 3
LK - Sri Lanka 3
PA - Panama 3
VE - Venezuela 3
BY - Bielorussia 2
EG - Egitto 2
JM - Giamaica 2
LU - Lussemburgo 2
NI - Nicaragua 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
Totale 6.027
Città #
Singapore 341
Ashburn 293
Dallas 256
San Jose 223
Santa Clara 201
Parma 137
Chandler 134
Hong Kong 128
Dublin 126
Ho Chi Minh City 108
Boardman 94
Council Bluffs 94
Beijing 87
Ann Arbor 83
Hanoi 80
Los Angeles 80
Milan 66
New York 66
Munich 52
Johannesburg 50
Shanghai 48
Bologna 43
Chicago 34
Dearborn 32
Hefei 31
Lauterbourg 31
Kissimmee 28
Santiago 28
Oceanside 27
Tokyo 24
Rome 23
London 22
Princeton 21
Buffalo 20
Nuremberg 19
Seoul 18
Brussels 16
Toronto 16
Columbus 15
Haiphong 15
Moscow 15
Vienna 15
Wilmington 15
Reggio Emilia 14
Rio de Janeiro 14
Turku 13
Helsinki 12
São Paulo 12
Da Nang 11
Montreal 11
Piacenza 11
Woodbridge 11
Frankfurt am Main 10
Houston 10
Hải Dương 10
Jakarta 10
Nanjing 10
Newark 10
Phoenix 10
Vitacura 10
Bengaluru 9
Boston 9
Jinan 9
Limena 9
Orem 9
Des Moines 8
Falls Church 8
Modena 8
Zhengzhou 8
Abidjan 7
Atlanta 7
Berlin 7
Brooklyn 7
Fontanellato 7
Guangzhou 7
Istanbul 7
Izmir 7
Mexico City 7
Riyadh 7
Seattle 7
Tashkent 7
The Dalles 7
Amsterdam 6
Ardea 6
Baghdad 6
Biên Hòa 6
Denver 6
Ghent 6
Indianapolis 6
Kunming 6
Lahore 6
Madison 6
Ottawa 6
Philadelphia 6
Pittsburgh 6
San Francisco 6
Tianjin 6
Addis Ababa 5
Amman 5
Bangkok 5
Totale 3.717
Nome #
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 330
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 324
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 258
Yeast-Based Functional Investigation of ELAC2 Variants in Mitochondrial Dysfunction 253
Yeast as a model for mitochondrial aminoacyl-tRNA synthetase disorders: validation of mutations in NARS2 and WARS2 196
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 189
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 184
Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds 181
Functional characterization of archaic-specific variants in mitonuclear genes: insights from comparative analysis in S. cerevisiae 168
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 166
Yeast as a model system for diseases associated with defective coenzyme a metabolism 163
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 162
Autosomal dominant myopathy caused by a novel ISCU variant 160
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 158
A yeast model for PKAN and CoPAN neurodegeration 157
Modeling in yeast of KARS pathogenic variants associated with a progressive and multi-systemic disease: impact on cytosolic and mitochondrial isoforms 157
Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometabolic syndrome 152
A novel de novo dominant mutation in ISCU associated with mitochondrial myopathy. 150
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 150
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 146
Bi-allelic KARS1 pathogenic variants affecting functions of cytosolic and mitochondrial isoforms are associated with a progressive and multisystem disease 145
Modeling human coasy mutations in yeast Saccharomyces cerevisiae 142
Investigation in yeast of novel variants in mitochondrial aminoacyl-tRNA synthetases WARS2, NARS2, and RARS2 genes associated with mitochondrial diseases 138
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 137
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 136
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 135
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 133
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 131
Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene 122
A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency 121
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 121
The power of yeast in modeling human mutations leading to mitochondrial disease 118
Evidence for a Conserved Function of Eukaryotic Pantothenate Kinases in the Regulation of Mitochondrial Homeostasis and Oxidative Stress 109
Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease 105
Yeast-based screening to discover therapies for Complex III assembly defects. 102
Yeast as a model for searching drugs against pathologies caused by mutations in ACO2 97
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 86
Functional analysis of human GCH1 variants using Saccharomyces cerevisiae as a model system 85
Functional characterization of archaic-specific variants in mitonuclear genes: power of the yeast model 67
Saccharomyces cerevisiae as a tool to assess the pathogenicity of human GCH1 variants 30
Decoding mitochondrial disorders using Saccharomyces cerevisiae 21
Yeast-based functional investigation of WARS2 variants and amino acid supplementation as a therapeutic strategy 20
Temporal transcriptional dynamics in HBV-specific CD8 T cells during long-term NUC therapy in HBeAg- chronic hepatitis B 19
Caratterizzazione funzionale di mutanti di lievito recanti mutazioni associate a patologia nei geni codificanti la pantotenato-chinasi e il CoA sintasi e identificazione di soppressori chimici 16
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B 16
Totale 6.156
Categoria #
all - tutte 20.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022130 0 3 0 11 6 18 15 9 8 8 7 45
2022/2023470 44 55 26 36 25 44 17 33 140 2 12 36
2023/2024470 41 53 26 39 20 54 43 26 15 39 35 79
2024/20251.376 48 64 82 97 172 174 69 77 209 101 97 186
2025/20262.868 233 323 328 212 306 164 326 106 388 214 145 123
2026/2027419 227 192 0 0 0 0 0 0 0 0 0 0
Totale 6.156